Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off.

New cell and gene therapies (CGTs) are offering great promise and tremendous challenges for the US healthcare system but with shocking initial costs.